Robotic Endoscopy Devices Market Size, Share & Industry Analysis By Product Type (Therapeutic, Diagnostic), By Application (Colonoscopy, Bronchoscopy, Laparoscopy, Gastrointestinal Endoscopy, Other), By End-user (Ambulatory Surgical Centres, Hospitals, Others) And Regional Forecast, 2024-2032

Endoscopy is a non-surgical procedure that is being used to examine a patient’s body. Robots in endoscopy are developed to overcome the limitations of standard diagnostic and therapeutic procedures and are broadly utilized in gastrointestinal diagnostics and minimally invasive surgery. Factors such as increased preference for minimally invasive surgical (MIS) procedures and product approvals by regulatory bodies such as U.S FDA, European Union’s CE marking are the significant factors driving the growth. For instance, according to Auris Health, the company had received the FDA clearance for its dubbed Auris Robotic Endoscopy System which is an advanced bronchoscope that aids in visualizing and treating several lung conditions.

The rising prevalence of chronic diseases like pancreatic cancers, inflammatory bowel disease, gastroesophageal reflux disease (GERD) due to unhealthy lifestyles, and the increasing geriatric population is estimated to drive the robotic endoscopy devices market over the forecast duration. For instance, In September 2018, according to CDC, more than half (51.8%) of U.S adults were diagnosed with chronic conditions such as cancer, chronic obstructive pulmonary disease, coronary heart disease, asthma, diabetes, etc., and 27.2% of US adults had multiple chronic conditions.

However, the higher price associated with robotic endoscopy devices is estimated to restrain the market growth during the forecast period. Additionally, the lack of skilled medical professionals for properly handling these devices hinders the market growth.

Key Market Driver -

Increasing Prevalence of Chronic Diseases to Boost Market Growth

Key Market Restraint -

High Cost of Robotic Endoscopy Devices

Market Segmentation:

Globally, the robotic endoscopy devices market can be segmented into product type, application, end-user, and region. Based on product type, the market has been divided into therapeutic, diagnostic. On the basis of application, the market can be segmented into colonoscopy, bronchoscopy, laparoscopy, gastrointestinal endoscopy, and others.  Furthermore, for an end-user segment, the market can be categorized into ambulatory surgical centers, hospitals, and others. Geographically, the robotic endoscopy devices market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

Key Players Covered:

Some of the major companies that are present in the robotic endoscopy devices market are Integra Lifesciences, Intuitive Surgical, TransEnterix, Inc., Auris Health, B Braun, Boston Scientific, Medtronic, and other prominent players

Key Insights:

• Technological Advancements in Robotic Endoscopy Devices Market


• Key Industry Developments – Merger, Acquisitions, and Partnerships


• Prevalence of Chronic Disease in Key Country/Regions


• Overview of Regulatory Scenario – Key Country/Region


• COVID-19 Impact on Robotic Endoscopy Devices Market

Regional Analysis:

Based on the segmentation of the region, the robotic endoscopy devices market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is projected to dominate the market in 2021 and is estimated to retain its leading position over the forecast duration. Factors such as well-established healthcare infrastructure, hospitals' financial capabilities to invest in robotic endoscopy devices, and a large patient pool are attributed to the growth of the market in North America.  Additionally, the rise in the geriatric population is also fueling the market growth as elder people are more prone to chronic conditions, such as cardiovascular, GI disorders, and other diseases that can positively impact the market. For instance, as per the RHI hub, more than 46 million older adults age 65 and older are living in the U.S, and the number is expected to grow to almost 90 million by 2050. The European region and APAC region is estimated to secure the second and third leading position in the market, respectively, owing to the factors such as the increased adoption of robotic systems in the healthcare sector along with that rise in the disposable income and healthcare expenditure in the developing countries like India and China. These factors combined with others are estimated to supplement the market growth in Europe and APAC regions for the coming years. The Latin America and the Middle East, and Africa market are expected to grow slower than other regions due to the limited penetration of advanced medical devices.

To gain extensive insights into the market, Request for Customization

Segmentation

Global Robotics Endoscopy Devices Market Industry Developments

• In March 2021, Asensus Surgical, Inc., a medical device company involved in digitizing the interface between the surgeon and patient, announced that it has received an additional FDA clearance for the Senhance Surgical System which is digital laparoscopic platform that leverages augmented intelligence to provide better patient outcomes through machine learning.


• In June 2020, AnX Robotica Corporation announced that the company got the clearance from Food and Drug Administration (FDA) De-Novo classification for its NaviCam Magnetically Controlled Capsule Endoscopy (MCCE) System. This allows complete, real-time visualization of the stomach utilizing a pill-sized capsule containing a camera and is remote-controlled by the physician.